Adaptive Biotechnologies Corp. (ADPT)
24.66
+0.32
(+1.31%)
USD |
NASDAQ |
Sep 02, 16:00
24.66
0.00 (0.00%)
After-Hours: 20:00
Adaptive Biotechnologies Cash from Investing (Quarterly) : -43.48M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.48M |
| March 31, 2026 | 9.143M |
| December 31, 2025 | -8.252M |
| September 30, 2025 | 17.28M |
| June 30, 2025 | 3.346M |
| March 31, 2025 | 25.57M |
| December 31, 2024 | 22.12M |
| September 30, 2024 | 5.287M |
| June 30, 2024 | 5.877M |
| March 31, 2024 | 44.51M |
| December 31, 2023 | 3.207M |
| September 30, 2023 | 26.14M |
| June 30, 2023 | 37.32M |
| March 31, 2023 | 62.98M |
| December 31, 2022 | -97.54M |
| September 30, 2022 | 58.02M |
| June 30, 2022 | 4.746M |
| Date | Value |
|---|---|
| March 31, 2022 | 37.69M |
| December 31, 2021 | 67.21M |
| September 30, 2021 | -21.27M |
| June 30, 2021 | 41.45M |
| March 31, 2021 | 93.82M |
| December 31, 2020 | -340.05M |
| September 30, 2020 | -97.25M |
| June 30, 2020 | 177.49M |
| March 31, 2020 | 142.76M |
| December 31, 2019 | 46.68M |
| September 30, 2019 | -260.85M |
| June 30, 2019 | -45.35M |
| March 31, 2019 | -222.18M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | 4.662M |
| March 31, 2018 | -36.69M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Personalis, Inc. | 38.16M |
| 10X Genomics, Inc. | -7.735M |
| Alamar Biosciences, Inc. (California) | -120.80M |
| Champions Oncology, Inc. | -0.238M |
| Medpace Holdings, Inc. | -23.88M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.40M |
| Cash from Financing (Quarterly) | 142.19M |
| Free Cash Flow | -24.03M |
| Free Cash Flow Per Share (Quarterly) | -0.0474 |
| Free Cash Flow to Equity (Quarterly) | -209.90M |
| Free Cash Flow to Firm (Quarterly) | -4.89M |
| Free Cash Flow Yield | -0.62% |